Towards Healthcare
GenAI in the Medtech Market Size, Dynamics and Opportunities

GenAI in the Medtech Market Dynamics, Research and Forecast

GenAI can automate repetitive tasks, simplify workflows, and minimize manual labor, resulting in major time and expense savings for medtech companies and numerous applications in different areas like drug discovery, surgical assistance, and personalized medicine. However, North America dominated the market in 2024, contributing factors such as the raised adoption of genAI in healthcare institutions, including hospitals, clinics, and diagnostic centers, and escalating development in novel drug discovery for chronic diseases.

Content

  • Insight Code: 5749
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

Discover how GenAI is transforming the Medtech market, with major growth expected from 2025 to 2034 due to tech and consumer shifts.

North America is currently leading the genAI in the medtech market due to the increased adoption of genAI in healthcare institutions, including hospitals, clinics, and diagnostic centers.

Some key players include Microsoft, Butterfly Network, DeepMind, and GE Healthcare.

Key trends include rising demand for drug discovery and personalized medicine, growth in diagnostics, innovation in clinical trials, and novel molecules.

The primary application of generative AI in healthcare is in documentation, coding, diagnosis decision support, administrative activities, information gathering, and translation.

The primary goal of using genAI in medical imaging is to enable medical professionals with additional visual prompts through denoising, realistic imaging, and reconstruction techniques.

Examples of generative AI in drug discovery are Insilico Medicine in clinical phases, Atomwise, which uses AI to select potential drug candidates, and Exscientia, which collaborates with pharmaceutical companies to identify and develop novel drugs using AI. 

PIB.GOV, NIH.GOV, CDC.GOV, US FDA.GOV, US GAO.GOV, INDIAAI.GOV
Any Questions